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Summary
Diffuse esophageal leiomyomatosis (DL), a benign
smooth-muscle-cell tumor, is characterized by abnormal
cell proliferation. DL is sometimes associated with X-
linked Alport syndrome (AS), an inherited nephropathy
caused by COL4A5 gene mutations. COL4A5 is tightly
linked, in a head-to-head fashion, to the functionally
related and coordinately regulated COL4A6 gene. No
X-linked AS cases are due to COL4A6 mutations, but
all DL/AS cases are always associated with deletions
spanning the 5′ regions of theCOL4A5/COL4A6 cluster.
Unlike the COL4A5 breakpoints, those of COL4A6 are
clustered within intron 2 of the gene. We identified a
DL/AS deletion and the first characterization of the
breakpoint sequences. We show that a deletion elimi-
nates the first coding exon of COL4A5 and the first two
coding exons of COL4A6. The breakpoints share the
same sequence, which, in turn, is closely homologous to
the consensus sequences of topoisomerases I and II. Ad-
ditional DNA evidence suggested that the male patient
is a somatic mosaic for the mutation. Immunohisto-
chemical analysis using a-chain–specific monoclonal an-
tibodies supported this conclusion, since it revealed the
absence of the a5(IV) and a6(IV) collagen chains inmost
but not all of the basement membranes of the smooth-
muscle-cell tumor. We also documented a similar seg-
mental staining pattern in the glomerular basement
membranes of the patient’s kidney. This study is partic-
ularly relevant to the understanding of DL pathogenesis
and its etiology.
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Introduction
Diffuse esophageal leiomyomatosis (DL;OMIM308940
[http://www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/
dispmim?308940]) is a benign smooth-muscle-cell tu-
mor characterized by diffuse proliferation of esophageal
smooth-muscle cells and at times is associated with gen-
ital and/or bronchial leiomyomatosis. TheDLphenotype
also has been associated with Alport syndrome (AS;
OMIM 301050 [http://www3.ncbi.nlm.nih.gov:80/
htbin-post/Omim/dispmim?301050]), in rare sporadic
as well as familial cases (Garcia-Torres and Orozco
1993). AS is an inherited nephropathy characterized by
progressive hematuria often associated with sensorineu-
ral deafness and ocular lesions. The syndrome is inher-
ited usually as an X-linked dominant trait or, less fre-
quently, as an autosomal recessive trait. Since the first
discovery of the molecular defect in X-linked AS, 1120
mutations have been identified in the COL4A5 gene
(Knebelmann et al. 1996; Renieri et al. 1996). COL4A5
codes for the common subunit of the type IV collagen
trimers in the glomerular basement membrane. Muta-
tions also have been reported in the genes for the a3(IV)
and a4(IV) chains (COL4A3 and COL4A4, respec-
tively) of individuals with the rare, autosomal recessive
form of AS (Lemmink et al. 1994; Mochizuki et al.
1994). In contrast, no AS case with a mutant COL4A6
gene has ever been reported. Like the COL4A3/
COL4A4 pair on chromosome 2, COL4A5 and
COL4A6 are tightly linked on chromosome X, in a
head-to-head organization, and share the same promoter
(Oohashi et al. 1994, 1995; Sugimoto et al. 1994).
Molecular studies recently have established a causal
relationship between the DL/AS phenotype and genomic
deletions extending from the 5′-end portion of COL4A5
to the 5′-end portion of COL4A6 and including the bi-
directional promoter (Zhou et al. 1993). Unlike the
COL4A5 breakpoints, the positions of which varied
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among different patients, another breakpoint was con-
sistently found within a relatively small segment of the
∼180-kb intervening sequence (IVS) III of COL4A6
(Kendall et al. 1997). Interestingly, larger deletions, ex-
tending beyond exon 3 of COL4A6, did not cause DL
and only caused AS (Heidet et al. 1995). The authors
therefore suggest that the IVS III deletion leads either to
the generation of a truncated COL4A6 product that
somehow is involved in DL pathogenesis or to the loss
of a gene within COL4A6 that, presumably, regulates
smooth-muscle-cell proliferation.
As a first step toward unraveling of the mechanism(s)
underlying DL, the present study was designed to elu-
cidate the composition of the deletion region of the ge-
nomic breakpoints in a DL/AS case. The results implicate
the possible involvement of topoisomerase enzymes in
the genomic rearrangement responsible for the DL/AS
phenotype and raise the possibility that there might be
a third gene in IVS III that is involved in the regulation
of smooth-muscle-cell proliferation.
Patients, Material, and Methods
Patient
The patient was a 19-year-old boy who, at the age of
6 years, was diagnosed with hematuria. A kidney-biopsy
specimen revealed only a mild mesangial proliferation.
Samples subjected to electron microscopic analysis con-
tained no glomeruli; therefore, ultrastructural analysis
of the glomerular basement membrane could not be per-
formed. At the age of 8 years, esophageal dysfunction
manifested itself, and the patient underwent esophago-
gastrectomy. The histological diagnosis was DL associ-
ated with AS. The patient’s renal function had gradually
worsened. There is no history of hematuria or esopha-
geal tumors in the patient’s family.
White Blood Cells and Southern Blot Analysis
Total genomic DNA was extracted and purified from
peripheral white blood cells of the patient and was used
for Southern blot analysis. No samples were available
from the patient’s parents. Some of the peripheral white
blood cells of the patient were used to establish Epstein-
Barr-virus–derived lymphoblastoid cell lines, in accor-
dance with the study by Maddalena et al. (1988). South-
ern blot hybridizations were performed by following
routine protocols (Sambrook et al. 1989). Likewise, a
commercially available EMBL3 human genomic library
(HL1111J and HL1006dn; Clontech) was screened, and
the resultant positive clones were purified and charac-
terized in accordance with standard procedures (Sam-
brook et al. 1989).
PCR Amplification
The patient’s genomic DNA was amplified with prim-
ers SK F2 (5′-ATA TAG CTG GAA AAG TGT GC-3′)
and YU20E1.8R1 (5′-TAA CTG GGA AAT GTC AGA
TAA C-3′). To make the 260-bp probe 2 (fig. 1B), we
designed a 5′ primer (5′-GGACACACACCATGACAT
GG-3′) and a 3′ primer (5′-ACC TGC GAA ACC ATC
ACA AC-3′). The reaction was performed by use of 50
ng genomic DNA, 0.5 mM each primer, 0.8 mM dNTPs,
1.5 mM Mg(OAc)2, 0.5 U rTth polymerase XL, and 1
# XL buffer (Perkin Elmer), in a total volume of 25 ml.
The PCR conditions were as follows: denaturation at
94C for 1 min and 30 cycles of 94C for 30 s, 58C
for 1 min, and 72C for 3 min, with a final elongation
at 72C for 10 min. PCR products were subcloned in
TA vectors (Invitrogen) and were sequenced with an ABI
373S automatic sequencer (Central Research Labora-
tory, Okayama University Medical School). Additional
oligonucleotides were synthesized for the subcloning and
sequencing of the deletion junction.
Immunohistochemical Staining
Normal portions of the esophagus were obtained from
an 80-year-old patient with stomach cancer, and normal
portions of kidney tissues were obtained from a 70–year-
old patient with renal cancer. Esophageal tumor samples
from the DL/AS patient were fixed in formaldehyde and
were embedded in paraffin. Previously established mon-
oclonal antibodies specific for the six a(IV) chains were
used for differential staining (Ninomiya et al. 1995).
Each sample was deparaffinized and stained under sev-
eral conditions, as described below. Since fresh renal
sections were not available, paraffin-embedded sections
were used for the analysis of type IV collagen chains.
Accordingly, the paraffin-embedded sections were sub-
jected to an antigen-retrieval procedure (Shin et al.
1991). In brief, sections were dipped in 0.2 M HCl (pH
0.9) and then were heated in a small autoclave (KT2322;
ALP Co., Ltd.), at different temperatures, for 6 min. The
suitable temperature for autoclaving was established em-
pirically for each specimen and basement membrane
(Naito et al. 1996). Optimal treatment for the kidney
sections was at 110C for 6 min, whereas that for the
esophageal tumors was at 121C or 127C. After antigen
retrieval, the paraffin-embedded sections were incubated
with antibodies, at room temperature, for 60 min. After
washing with phosphate-buffered saline, the antibodies
were detected with a Labeled Streptavidin-biotinin kit
(DAKO Co.).
Ueki et al.: Mutation Analysis of Leiomyomatosis 255
Figure 1 Relative location of the three genomic DNA fragments (A), and restriction map of genomic DNA of the normal allele and the
patient’s mutant allele (B). The relative location of the three overlapping clones is shown, and representative restriction sites are indicated by
uppercase letters: E  EcoRI; S  SalI; X  XhoI; B  BamHI; K  KpnI; A  ApaI; and P  PstI. Uppercase letters within parentheses
indicate cloning sites. Uppercase letters with an asterisk (*) indicate the restriction sites that were estimated by genomic Southern hybridization.
The name of each clone is given under the clone, and the numbers within parentheses indicate the size of each clone. Restriction sites of the
normal allele (B) are drawn in correspondence with the three isolated clones. As indicated, the two genes, COL4A5 and COL4A6, are closely
located and are arranged head to head. Exons 1 and 1′ of theCOL4A6 gene are used alternatively (Sugimoto et al. 1994). For better understanding,
only COL4A6 introns are indicated, as IVS I, II, and III. Blackened and unblackened boxes indicate exons, with the exon number given above
the box. Several characteristic elements (i.e., L1, Alu, and the MER19 homologous sequence) are indicated by different types of boxes (Scott
et al. 1987; Britten et al. 1988; Kaplan et al. 1991). The location of the 17-kb deletion is indicated on both the normal and the mutant alleles.
Probes 1 and 2, used for the genomic Southern hybridization (fig. 2), and the two PCR primers are shown by blackened bars and by the two
small arrows, respectively.
Results
Identification of the DL/AS Deletion and Evidence for
Mosaicism
Since all DL/AS cases reported to date have a deletion
of the first three exons (1′, 1, and 2) of COL4A6, we
isolated overlapping genomic clones from this region,
for detailed analysis of our patient. These were obtained
after screening a library containing normal humanDNA,
with the sense COL4A6 cDNA. After isolation of the
first positive clone (AF2; fig. 1A), the screenwas repeated
with AF2 end probes, resulting in the identification of
two additional recombinants (YU19 and YU20; fig. 1A).
Together, they extended for 130 kb of DNA, from IVS
I of COL4A5 to IVS III of COL4A6 (fig. 1B).
A 1.8-kb genomic probe corresponding to the 5′ seg-
ment of IVS III of COL4A6 (probe 1; fig. 1B) was used
in the Southern analysis of the patient’s DNA digested
with BamHI. On the basis of the restriction map of the
genomic clones, the expected size of the normal allele
was 23 kb (fig. 1B). Consistent with this prediction, a
single band of 23 kb was seen in the control samples,
prepared from an unaffected male (fig. 2A, lane 2) and
an unaffected female (fig. 2A, lane 3), with the intensity
of the former noticeably weaker than that of the latter.
In contrast, a new and smaller band of ∼6 kb was noted
for the patient’s DNA (fig. 2A, lane 1). The opposite
size differences were observed with PstI-digested DNA
hybridized to the same probe (data not shown). When
considered together, the results suggested a 17-kb dele-
tion extending from 3′ of the third PstI site of IVS III of
COL4A6 to immediately 5′ of the BamHI site of IVS I
of COL4A5 (fig. 1B).
Interestingly, both the BamHI (fig. 2A) and PstI (data
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Figure 2 Results of genomic Southern hybridization. Total ge-
nomic DNA was digested with (A) BamHI or (B) EcoRI. The blots
were hybridized with (A) probe 1 (fig. 1B) or (B) probe 2, located in
COL4A5 intron 1 (fig. 1B). Five micrograms of DNA were loaded on
each lane. Lane Pt, DNA extracted from peripheral white blood cells
of the DL/AS patient. Lane M, Unaffected male control. Lane F, Un-
affected female control. Note that the 6-kb band appears in the pa-
tient’s DNA (A).
Figure 3 Results of PCR amplification of the junctional fragment
from DNA of the DL/AS patient. Lane 1, l HindIII size markers. Lane
2, Normal control DNA used as a template. Lane 3, DL/AS patient’s
DNA from peripheral white blood cells used as a template. Note that
the amplified band from the two primers, SK F2 and YU20E1.8R1,
was 3.2 kb. This fragment was subcloned, and the nucleotide sequence
was determined. The relative locations of the primers and the amplified
fragment are indicated in figure 1B.
not shown) digests of the DL/AS sample also displayed
the bands corresponding to the normal allele. The iden-
tical finding was noted when EcoRI-digested DNA from
the patient’s peripheral blood was hybridized to a probe
corresponding to the 5′ portion of IVS I of COL4A5
(probe 2; fig. 2B). However, in all samples, the so-called
mutant-allele band was consistently darker than the so-
called normal-allele band, thus raising the possibility of
somatic mosaicism.
Characterization of the Deletion Breakpoints
The results described above suggest that the DL/AS
mutation is within the 23-kb BamHI fragment of the
normal allele (fig. 1B). Thus, we next focused on deter-
mining the nucleotide sequences around the presumptive
breakpoints, one around the BamHI site near probe 2
and the other around the PstI and EcoRI sites near probe
1. To determine these sequences, two primers were de-
signed to verify the deletion, by PCR amplification of
genomic DNA. Consistent with our prediction that only
the mutant allele would amplify, only the mutant 3.2-
kb PCR product was obtained after amplification of
DNA from the patient’s peripheral blood (fig. 3). This
product was sequenced in its entirety and was compared
with the respective segments of the COL4A5 and
COL4A6 genes.
The comparison demonstrated that the COL4A5 side
of the breakpoint resides within the L1 transposable el-
ement (as mentioned below) and that the COL4A6 side
is at nucleotides 3570–3576 of IVS III of the COL4A6
gene. Therefore, the deletion includes 12 kb of intron
1, exon 1 of COL4A5, the bidirectional promoter, and
from exon 1′ to 3 kb within IVS III of COL4A6 (see fig.
1B). Nucleotide-sequence alignment around the break-
points showed that they display CATCATC junctional
homology (fig. 4). Interestingly, the breakpoints have six
topoisomerase I consensus sequences on both strands.
The COL4A6 breakpoint also exhibits a 90% match to
the topoisomerase II consensus sequence. A 6-bp direct
repeat, AAATGC, and a sequence homologous to Alu
also were located near both the COL4A5 and COL4A6
breakpoints. There was no nucleotide insertion or de-
letion in the junctional fragment.
Mosaic Loss of Normal Basement-Membrane
Architecture
In order to relate the genotypic findings to the patient’s
phenotype, we immunohistochemically analyzed the
basement membranes surrounding the smooth-muscle
cells at the lower esophageal region and those of kidney
glomeruli, using antibodies for each of the type IV col-
lagen chains. The esophageal sample from an unaffected
individual showed positive staining with monoclonal an-
tibodies specific for the a1(IV), a2(IV), a5(IV), and
a6(IV) chains (fig. 5A, B, E, and F, respectively). As was
expected, antibodies against the a3(IV) and a4(IV)
chains did not show any positive signals in this tissue
(fig. 5C and D, respectively). In the DL/AS sample, the
same antibodies visualized the a1(IV) and a2(IV) chains
(fig. 5G and H, respectively) and failed to do so with
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Figure 4 Nucleotide sequences of normal and mutant alleles, at the breakpoints. The relative location of the 17-kb deletion is shown in
figure 1B. Nucleotide sequences of part of intron 1 of COL4A5 (top), part of IVS III of COL4A6 of the normal allele, across the breakpoints
(bottom), and the corresponding region from the mutant allele in one strand (middle) are aligned. The asterisks (*) indicate the nucleotide
matches. Note that the COL4A5 intron 1 sequence and the mutant-allele sequence match completely up to the central CATCATC sequence.
The 3′ side of the CATCATC sequence of the mutant allele and the COL4A6 IVS III sequence are also the same. Short and long arrows indicate
the consensus sequences of topoisomerase I (5′-A/T-G/C-T/A-T-3′) (Been et al. 1984) and topoisomerase II (5′-A/G-N-T/C-NNCNNG-T/C-NG-
G/T-TN-T/C-N-T/C-3′) (Spitzner and Muller 1988), respectively. Underlined sequences indicate the 6-bp direct repeat. Shaded letters and
lowercase letters represent the L1 sequence and the sequence homologous to Alu, respectively.
the a3(IV) and a4(IV) chains (fig. 5I and J, respectively).
However, the expression patterns of the a5(IV) and
a6(IV) chains were significantly different from those of
the control samples.With the exception of a few smooth-
muscle cells, most of the basement membranes were un-
reactive with these two antibodies (fig. 5K and L). Aside
from differing from the normal pattern, the uneven dis-
tribution of the a5 and a6 epitopes in the DL/AS sample
indirectly supports the DNA evidence for somatic mo-
saicism of the COL4A5/COL4A6 deletion.
In a normal kidney-cortex sample, the a1(IV) and
a2(IV) chains in all basement membranes were stained
(fig. 5M and N, respectively). Likewise, the a3(IV),
a4(IV), and a5(IV) chains showed the same positive ex-
pression pattern in glomerular basementmembranes and
in some parts of the tubular basement membranes (fig.
5O, P, and Q, respectively). Consistent with our pre-
vious data, anti-a6(IV) did not show any positive stain-
ing with glomerular basement membranes but did so
with some tubular and the Bowman basement mem-
branes (fig. 5R) (Ninomiya et al. 1995). In the patient’s
sample, the expression patterns of the a1(IV) and a2(IV)
chains were the same as those in normal tissue (fig. 5S
and T, respectively). However, the staining patterns of
the a3(IV), a4(IV), and a5(IV) chains in glomerular
basement membranes were segmental (fig. 5U, V, and
W, respectively). A similar discontinuous pattern was
observed for the a6(IV) antibody, in the Bowman and
in some tubular basement membranes (fig. 5X). Hence,
the affected tissues of the DL/AS patient displayed a
pathology consistent with the loss of COL4A5 and
COL4A6 gene products in most, but not all, the cells.
Discussion
Deletions are a common type of mutation found in
many organisms. The characterization of a deletion con-
sisting of the juxtaposition of noncontiguous sequences
as a result of the breaking and rejoining of the DNA
strands provides an excellent opportunity to study the
mechanisms that are involved in the generation of mu-
tations in the mammalian genome. A previous report
involved the partial characterization of the deletions for
DL/AS (Heidet et al. 1995). However, in this paper, we
have reported the first detailed analysis of a 17-kb de-
letion that included the upstream regions of both the
COL4A5 and COL4A6 genes and the presumptive com-
mon promoter region for both genes, from a case of DL/
AS. The deletion encompassing the two collagen genes
caused two disease states, DL and AS, although one of
the genes, COL4A5, is already known to be linked to
AS.
It has been postulated that topoisomerases I and II
may be involved in recombinational events, since these
enzymes form covalent linkages in both strands of the
DNA helix and can cause a single-strand break and a
transient double-strand break in the helix (Bae et al.
1988; Champoux and Bullock 1988). Hu et al. (1991)
suggested that the enzymes are able to cleave DNA
strands, during duplication of the dystrophin gene, and
several investigations have reported that topoisomerase
I and II sites were found at the breakpoints of translo-
cations or deletions in the dystrophin and steroid sul-
fatase genes (Shapiro et al. 1989; Bodrug et al. 1991;
van Bakel et al. 1995). In the DL/AS case, the consensus
sequences of topoisomerase I and II binding sites were
found at the breakpoints. In particular, six topoisomer-
ase I consensus sequences existed on both strands, in the
CATCATC junctional homologous sequence. These re-
sults suggest that topoisomerase I and II activity may be
involved in the mechanisms of DNA breakage and
reunion.
The common mechanism involved in large gene de-
letions is recombination. There are two types of recom-
bination events: one is the homologous unequal recom-
bination between gene sequences or between repetitive
sequence elements, and the other is nonhomologous re-
combination between DNA sequences with short ho-
Figure 5 Distribution of a(IV) chains in esophageal smooth muscles and kidney from a normal control and from the DL/AS patient.
a(IV)-Chain–specific monoclonal antibodies (H11, H21, H31, H44, H52, and H63) (Ninomiya et al. 1995) were used for immunostaining.
When smooth muscles in the lower esophageal region were stained, antibodies against a1, a2, a5, and a6 chains (A, B, E, and F, respectively),
but not those against a3 and a4 chains (C and D, respectively), showed positive signals in the basement membranes surrounding the smooth-
muscle cells. However, although the expression patterns for a1, a2, a3, and a4 chains were almost the same in tumor tissues (G, H, I, and J,
respectively) as in control tissues (A, B, C, and D, respectively), most of the basement membranes around smooth-muscle cells were negative
for a5 and a6 antibodies (K and L, respectively). In the normal kidney, a1 and a2 chains were coexpressed in all basement membranes (M
and N, respectively), whereas a3, a4, and a5 chains were colocalized in glomerular basement membranes (O, P, and Q, respectively), and a5
and a6 chains were coexpressed in Bowman basement membranes (Q and R, respectively). Distribution of a1 and a2 chains was the same in
the patient’s kidney (S and T, respectively) as in that of the control (M and N, respectively). However, a3, a4, and a5 chains showed a segmental
pattern (indicated by arrows) in glomerular basement membranes (U, V, and W, respectively). In Bowman capsule and tubular basement
membranes, the a6 chain showed a discontinuous pattern (X, between the two small arrows).
Ueki et al.: Mutation Analysis of Leiomyomatosis 259
mology (Cooper and Krawczak 1993). Efstratiadis et al.
(1980) reported that, in eukaryotic genes, short direct
repeats are involved in the generation of deletions by
slipped mispairing during DNA replication. Nonhom-
ologous recombination could cause large DNA rear-
rangements (Albertini et al. 1982). In the b-globin gene
of HPFH-2 (hereditary persistence of fetal hemoglobin),
a short direct repeat was observed at the junctions of a
1100-kb deletion (Henthorn et al. 1990). The deletion
of the COL4A5 and COL4A6 genes presented here
could have involved the short repeat sequence CAT-
CATC, located only at both breakpoints. Nicked or
gapped breakpoints caused by topoisomerase I and II
could contribute to a single-strand loop excision during
slipped mispairing.
Another interesting finding was that the breakpoint
on theCOL4A5 side was located within the L1 repetitive
element. Several examples of large deletions at the L1
elements have been reported, including that in the b-
globin gene (Henthorn et al. 1990), althoughmanymore
deletions through Alu repetitive elements have occurred
in the genome (Ottolenghi and Giglioni 1982; Lehrman
et al. 1985, 1986; Li and Bray 1993).
Genomic Southern analysis using DNA from periph-
eral white blood cells suggested somatic mosaicism. Im-
munohistochemical data from the basement membranes
of glomeruli and of some tubules also supported this
idea. Interestingly, it is the smooth-muscle cells prolif-
erating preferentially in the esophageal region that cause
the DL phenotype. This could be because the mutant
cells have gained a growth abnormality, owing to the
17-kb deletion at the Xq22 region. We think that this
implies the possibility that a large deletion in the
COL4A6 gene, during somatic mitosis, could cause DL,
even if the lesion is limited within the esophagus.
The expression of the COL4A5 and COL4A6 genes
was blocked completely in most of the tumor tissues.
Heidet et al. (1995, 1997) had detected transcription
from exon 4 of the COL4A6 gene, by reverse-transcrip-
tase PCR, and had suggested the possibility that an ab-
normal truncated a6(IV) chain could cause DL. How-
ever, we think it unlikely that the triple-helix collagen
molecules that contain the abnormal truncated a6(IV)
chains could be responsible for the pathogenesis of DL,
because we could not detect, by immunohistochemical
analysis, collagen molecules containing the a6(IV) chain,
in most of the smooth-muscle cells of the tumor. What,
then, causes DL in the cases of deletion of the upstream
region of both the COL4A5 and COL4A6 genes? Since
one case having a large deletion containing the entire
COL4A6 gene represented only the AS and not the DL
phenotype (Heidet et al. 1995), it is not plausible that
the entire loss of COL4A6 expression causes DL.
Our hypothesis is that a third gene and/or its regu-
latory elements, within the 180-kb IVS III (Kendall et
al. 1997), may regulate smooth-muscle-cell prolifera-
tion. In our DL/AS patient, the 17-kb deletion may have
hit one of the regulatory elements and thus may have
changed the expression of the third gene. Several AS
cases that contained larger deletions, ranging from
COL4A5 IVS I to COL4A6 IVS IV, did not show the
DL phenotype (Heidet et al. 1995). We think that the
deletions in these AS cases all include the entireCOL4A6
IVS III, which presumably contains the third gene, to-
gether with its regulatory elements, and therefore no
obvious phenotypic changes were detected. A similar
situation has been reported for other benign mesenchy-
mal tumors, such as uterine leiomyoma, lipoma, and
hamartoma (Schoenmakers et al. 1995). Schoenmakers
et al. demonstrated that a gene for one of the high-
mobility-group proteins, HMGl-C, was disrupted, and
fusion transcripts were detected in several benign solid
tumors, suggesting a link between a gene for a member
of the high-mobility-group proteins and development of
benign solid tumors. Other studies, reported by de Kok
et al. (1995, 1996), have suggested that X-linked deaf-
ness can be caused by an 8-kb deletion ∼900 kb from
the POU3F4 gene. de Kok et al. (1995, 1996) assumed
that the 8-kb region contains some cis regulatory ele-
ments (a promoter and/or an enhancer) for transcription
of the gene. We also believe that the 17-kb deleted re-
gion, especially the COL4A6 IVS III, contains several
essential genes and/or cis elements that could regulate
smooth-muscle-cell proliferation, as mentioned above.
As an approach to answer this question, gene targeting
using constructs lacking the entire or a part of IVS III
could be performed. However, the possibility that the
truncated a6(IV) chain could cause the DL phenotype
cannot be ignored (Heidet et al. 1995). This possibility
can be tested by experiments on cDNA transfection of
the truncated form of the a6(IV) chain into smooth-
muscle cells.
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